Epidemiology of bacteriuria caused by vancomycin-resistant enterococci--a retrospective study
- PMID: 10926703
- DOI: 10.1067/mic.2000.106904
Epidemiology of bacteriuria caused by vancomycin-resistant enterococci--a retrospective study
Abstract
Background: The epidemiology of vancomycin-resistant enterococcal (VRE) bacteriuria has not been previously described. Our objectives are to describe the frequency of VRE bacteriuria, to use strict definitions to distinguish symptomatic urinary tract infection (UTI) versus urine colonization without pyuria versus asymptomatic bacteriuria with pyuria, and to describe the outcomes of each group.
Methods: We used a retrospective analysis of patients with VRE bacteriuria in an academic medical center.
Results: During the 18-month study period, 98 of the 107 patients (92%) with urine cultures positive for VRE (23/10,000 admissions), had charts that were available for review. In 94 of 98 patients, the organism was Enterococcus faecium, and in only 4 was Enterococcus faecalis recovered. Thirty-seven patients were colonized with VRE; 21 patients had asymptomatic bacteriuria, and the status of 27 patients was not ascertainable. Thirteen patients had VRE UTIs with two associated bacteremias and one death. Patients with UTI versus patients without UTI were more likely to have an underlying malignancy (39% vs 9%, P =.014).
Conclusion: The majority of urine cultures yielding VRE do not represent true infection, rather colonization or asymptomatic bacteriuria.
Similar articles
-
Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.J Microbiol Immunol Infect. 2008 Apr;41(2):124-9. J Microbiol Immunol Infect. 2008. PMID: 18473099
-
Evaluation of the treatment of vancomycin-resistant enterococcal urinary tract infections in a large academic medical center.Ann Pharmacother. 2013 Feb;47(2):159-69. doi: 10.1345/aph.1R419. Epub 2013 Jan 22. Ann Pharmacother. 2013. PMID: 23341161
-
Treatment of vancomycin-resistant Enterococcus faecium infections.Arch Intern Med. 1996 Dec 9-23;156(22):2579-84. Arch Intern Med. 1996. PMID: 8951301
-
Vancomycin-resistant enterococcal urinary tract infections.Pharmacotherapy. 2010 Nov;30(11):1136-49. doi: 10.1592/phco.30.11.1136. Pharmacotherapy. 2010. PMID: 20973687 Review.
-
[Vancomycin resistant enterococci in the Netherlands].Ned Tijdschr Geneeskd. 2004 May 1;148(18):878-82. Ned Tijdschr Geneeskd. 2004. PMID: 15152389 Review. Dutch.
Cited by
-
Atomic force microscopy study of the effect of antimicrobial peptides on the cell envelope of Escherichia coli.Antimicrob Agents Chemother. 2005 Oct;49(10):4085-92. doi: 10.1128/AAC.49.10.4085-4092.2005. Antimicrob Agents Chemother. 2005. PMID: 16189084 Free PMC article.
-
Clinical significance of bacteriuria with low colony counts of Enterococcus species.Eur J Clin Microbiol Infect Dis. 2006 Apr;25(4):238-41. doi: 10.1007/s10096-006-0132-0. Eur J Clin Microbiol Infect Dis. 2006. PMID: 16596356
-
Linezolid to treat urinary tract infections caused by vancomycin-resistant Enterococcus.SAGE Open Med. 2020 Nov 4;8:2050312120970743. doi: 10.1177/2050312120970743. eCollection 2020. SAGE Open Med. 2020. PMID: 33209303 Free PMC article.
-
Vancomycin resistance has no influence on outcomes of enterococcal bacteriuria.J Hosp Infect. 2013 Nov;85(3):183-8. doi: 10.1016/j.jhin.2013.07.007. Epub 2013 Aug 30. J Hosp Infect. 2013. PMID: 23998947 Free PMC article.
-
Treatment of resistant enterococcal urinary tract infections.Curr Infect Dis Rep. 2010 Nov;12(6):455-64. doi: 10.1007/s11908-010-0138-8. Curr Infect Dis Rep. 2010. PMID: 21308555
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical